Molecular Determinants of Occult Metastatic Tumor Cells in Bone Marrow
- 1 October 2001
- journal article
- review article
- Published by Elsevier in Clinical Breast Cancer
- Vol. 2 (3) , 222-228
- https://doi.org/10.3816/cbc.2001.n.025
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast CancerNew England Journal of Medicine, 2000
- Detection of Minimal Disease in Patients with Solid TumorsJournal of Hematotherapy, 1996
- Methodological Analysis of Immunocytochemical Screening for Disseminated Epithelial Tumor Cells in Bone MarrowJournal of Hematotherapy, 1994
- Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.Journal of Clinical Oncology, 1991
- Detection of micrometastatic tumor cells in bone marrow of breast carcinoma patientsJournal of Surgical Oncology, 1991
- Use of monoclonal antibody MBr1 to detect micrometastases in bone marrow specimens of breast cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1990
- Immunohistochemical staining of bone marrow biopsies for detection of occult metastasis in breast cancerBreast Cancer Research and Treatment, 1990
- Monoclonal antibody detection of carcinoma cells in bone marrow biopsy specimens from breast cancer patientsCancer, 1988
- Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies.Proceedings of the National Academy of Sciences, 1987
- Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases.BMJ, 1987